Responses
Regular and Young Investigator Award Abstracts
Combination Immunotherapies
870 CoREST inhibition by TNG260 increases expression of immunomodulatory genes in STK11-mutant cancer and sensitizes to immune checkpoint blockade
Compose a Response to This Article
Other responses
No responses have been published for this article.
